Skip to content

Oxytocin's Effect on Attention Training

An Eye-tracking Study to Investigate Oxytocin's Effect on Attentional Bias Training

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03128242
Enrollment
60
Registered
2017-04-25
Start date
2016-11-25
Completion date
2018-12-30
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

oxytocin, attention bias, attention training, eye-tracking

Brief summary

This study aims to investigate oxytocin's effect on attentional bias training. Healthy participants will undergo a dot-probe task-based training to direct their attention away from negative stimuli (as compared to neutral). Effects of the training will be assessed using an eye-tracking anti-saccade task.

Detailed description

In this study, a dot-probe task will be used to examine if subjects show an attentional bias towards negative stimuli and whether the bias can be modified using a subsequent attentional bias training. During this training participants learn to direct their attention away from threatening stimuli. In a between-subject placebo controlled design participants will receive either intranasal oxytocin or placebo before the training to examine whether oxytocin could facilitate the effects of the attention training. Effects of the training and of oxytocin on the training will be assessed by means of an eye-tracking anti-saccade task. Based on previous studies showing the strongest effects of threat-attentional bias training in high anxious subjects, the study will recruit participants with an elevated trait anxiety.

Interventions

DRUGOxytocin

intranasal administration of oxytocin (24IU)

DRUGplacebo

intranasal administration of placebo (24IU)

Sponsors

University of Electronic Science and Technology of China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* male participants with elevated trait anxiety (\> 45 scores as assessed with the State and Trait Anxiety Inventory, Spielberger, 1983) * without past or current psychiatric or neurological disorders

Exclusion criteria

* history of head injury * medical or psychiatric illness * smoking or drinking 24 hours before the experiment

Design outcomes

Primary

MeasureTime frameDescription
Reaction time (RT) difference - oxytocin effectsBefore drug administration (pre-treatment baseline) and 55 minutes after drug administrationDifference before and after oxytocin administration: reaction time to negative and neutral stimuli in the dot-probe task
Reaction time (RT) difference - training effectsBefore drug administration - 55-90 minutes after drug administrationDifference before and after training: reaction time to negative and neutral stimuli in the dot-probe task
Saccade latency difference - training effectsBefore drug administration - 55-90 minutes after drug administrationDifference before and after training in saccade latency in the anti-saccade task

Countries

China

Contacts

Primary ContactBenjamin Becker, Dr.
ben_becker@gmx.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026